Trial Profile
14C-ARN-509 Microdose Absolute Bioavailability and Microtracer Absorption, Metabolism, and Excretion Study in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2019
Price :
$35
*
At a glance
- Drugs Apalutamide (Primary) ; Apalutamide (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- Sponsors Aragon Pharmaceuticals
- 20 Feb 2019 Results evaluating the absolute bioavailability and absorption, metabolism, and excretion of apalutamide in healthy men published in the Drug Metabolism and Disposition
- 05 Nov 2014 New trial record